INTERNATIONAL PATENT: SUNGKWANG MEDICAL FOUNDATION, 의료법인 성광의료재단 FILES APPLICATION FOR "DISEASE-SPECIFIC BIOMARKER FOR PREDICTING AND DIAGNOSING PRE-ECLAMPSIA IN MID-PREGNANCY AND USE THEREOF"

GENEVA, June 11 -- SUNGKWANG MEDICAL FOUNDATION (566 Nonhyeon-ro,Gangnam-gu,Seoul 06135), 의료법인 성광의료재단 (서울특별시강남구논현로 566) filed a patent application (PCT/KR2024/016714) for "DISEASE-SPECIFIC BIOMARKER FOR PREDICTING AND DIAGNOSING PRE-ECLAMPSIA IN MID-PREGNANCY AND USE THEREOF" on Oct 29, 2024. With publication no. WO/2025/116316, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): R...